Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Phase II Trial of Arsenic Trioxide in Relapsed and Refractory Hodgkin's Disease

NCT00005595 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT00005595
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00005595 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Phase II Trial of Arsenic Trioxide in Relapsed and Refractory Hodgkin's Disease
Lead sponsor
Northwestern University
Phase
Phase 2
Overall status
Terminated
Start date
June 30, 2000
Completion date
April 30, 2002
Enrollment
2 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma